Skip to main content

Peer Review reports

From: Overall survival of patients with hepatocellular carcinoma treated with sintilimab and disease outcome after treatment discontinuation

Original Submission
4 Apr 2023 Submitted Original manuscript
1 May 2023 Reviewed Reviewer Report
6 May 2023 Reviewed Reviewer Report
28 May 2023 Author responded Author comments - Shu-Qun Cheng
Resubmission - Version 2
28 May 2023 Submitted Manuscript version 2
30 May 2023 Author responded Author comments - Shu-Qun Cheng
Resubmission - Version 3
30 May 2023 Submitted Manuscript version 3
29 Jun 2023 Reviewed Reviewer Report
1 Jul 2023 Reviewed Reviewer Report
20 Jul 2023 Author responded Author comments - Shu-Qun Cheng
Resubmission - Version 4
20 Jul 2023 Submitted Manuscript version 4
Publishing
6 Oct 2023 Editorially accepted
23 Oct 2023 Article published 10.1186/s12885-023-11485-y

You can find further information about peer review here.

Back to article page